UK researchers have found that people with longer-term COVID-19 symptoms including brain fog showed reduced performance in tasks testing different mental processes up to two years after infection with the virus.
FDA challenges safety, efficacy of Geron’s imetelstat ahead of advisory committee meeting
The FDA said Tuesday that it is unconvinced the benefits of Geron’s imetelstat outweigh the risks in certain anemic myelodysplastic syndrome (MDS) patients who are
March 13, 2024